Výsledky vyhledávání
- 1.CHRASTINOVÁ, L.G; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; CEZNEROVÁ, E.; KOTLÍN, R.; PECHERKOVÁ, P.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; HAVLÍČEK, M.; VÁLKA, J.; HOMOLA , J.; SUTTNAR, J. Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array. Scientific reports. 2023, vol. 13, no. 1, art. no. 12816. ISSN 2045-2322.
- 2.HLAVACKOVA, A.; VYDRA, J.; KOVAROVA, H.; CHRASTINOVA, L.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Significant differences of serum metabolism in acute myeloid leukemia WITH IDH2 mutations. [Prezentováno: EHA-SWG scientific meeting on MDS/MPN/AML: commonalities and differences of myeloid neoplasms. Budapest, 2.11.-4.11.2023.].
- 3.HRUSTINCOVA, A.; TRSOVA, I.; KREJCIK, Z.; KUNDRAT, D.; BELICKOVA, M.; KAISRLIKOVA, M.; VESELA, J.; KLEMA, J.; RYSAVY, P.; SUTTNAR, J.; HLAVACKOVA, A.; JONASOVA, A.; CERMAK, J.; DOSTALOVA MERKEROVA, M. SF3B1 mutations and their impact on cellular bioenergetics in myelodysplastic syndromes. Leukemia research. 2023, vol. 128, no. Supplement, s. 71. ISSN 0145-2126.
- 4.SVOBODA, N.; KOČÍ, K.; SEIDLOVÁ, A.; MANDYS, V.; SUTTNAR, J.; HLAVÁČKOVÁ, A.; ET AL. Oxidative stress as a reliable biomarker of carotid plaque instability: a pilot study. Antioxidants. 2023, vol. 12, no. 2, art. no. 506. ISSN 2076-3921.
- 5.CHRASTINOVÁ, L.; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; VÁLKA, J.; HOMOLA J.; SUTTNAR, J. Aberrant glycosylation patterns in myelodysplastic syndrome: a lectin array study. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 6.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; KOVAROVA, H.; STIKAROVA, J.; SUTTNAR, J. Targeted metabolomic profiling of AML patients: the effect of conditioning regimens on post-transplantation complications. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 7.KOSEK, V.; HAJŠL, M.; BECHYŇSKÁ, K.; KUČERKA, O.; SUTTNAR, J.; HLAVÁČKOVÁ, A.; ET AL. Long-term effects on the lipidome of acute coronary syndrome patients. Metabolites. 2022, vol. 12, no. 2, art. no. 124. ISSN 2218-1989.
- 8.VALENTA, J.; HLAVACKOVA, A.G; STACH, Z.; STIKAROVA, J.; HAVLICEK, M.; MICHALEK, P. Fibrinogenolysis in venom-induced consumption coagulopathy after Viperidae snakebites: a pilot study. Toxins. 2022, vol. 14, no. 8, art. no. 538. ISSN 2072-6651.
- 9.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Metabolic alterations and elevation of oxidative stress during the early post-transplant period in AML patients. Blood. 2022, vol. 140, no. S1, s. 11833. ISSN 0006-4971.
- 10.CEZNEROVÁ, E.; KAUFMANOVÁ, J.; HAVLÍČEK, M.; PASTVA, O.; HLAVÁČKOVÁ, A.; KOTLÍN, R.; SUTTNAR, J. Impact of genetic and post-translational modifications on structure and function of fibrinogen. Blood. 2022, vol. 140, no. S1, s. 2719. ISSN 0006-4971.